FDA 2004 Reg Agenda Includes "Complete Response" Rule, Electronic Drug Listing
This article was originally published in The Pink Sheet Daily
Executive Summary
The regulatory plan also states that a proposed rule on treatment use of investigational drugs is scheduled for October. A guidance on pregnancy labeling is planned for 2005.